Dermatitis atopic
Not recruitingStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:Rocatinlimab
Germany- Participants:18–64 years · 65+ years
- Substances:Rocatinlimab
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany232 clinical trials in Stuttgart, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic prostate cancer, diffuse large B-cell lymphoma, and bladder cancer treatments. Studies evaluate novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Several trials investigating breakthrough treatments for various forms of leukemia and solid tumors.
Research focusing on cytomegalovirus prevention and influenza vaccination in different age groups. Studies evaluate innovative vaccine formulations and immune responses.
Trials aim to enhance vaccine efficacy and improve protection against infectious diseases.
Studies addressing weight management and various eye conditions including retinal disorders. Research includes innovative treatments for macular degeneration and vision preservation.
Focus on developing treatments that improve patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.